|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 9/64 | (2006.01) |
| C12N 15/57 | (2006.01) | ||
| A61K 38/48 | (2006.01) |
| (11) | Number of the document | 3581650 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19174517.3 |
| Date of filing the European patent application | 2009-09-15 | |
| (97) | Date of publication of the European application | 2019-12-18 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-28 |
| (46) | Date of publication of the claims translation | 2023-05-10 |
| (30) | Number | Date | Country code |
| BO20080564 | 2008-09-15 | IT | |
| BO20090275 | 2009-05-06 | IT |
| (72) |
Simioni, Paolo , IT
|
| (73) |
uniQure biopharma B.V. ,
Paasheuvelweg 25a, 1105 BP Amsterdam,
NL
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Faktoriaus IX polipeptido mutantas, jo panaudojimas ir jo gamybos būdas |
| FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION |
| Payment date | Validity (years) | Amount | |
| 2025-07-24 | 17 | 347.00 EUR |
| 2026-09-15 |